Degenerative Disease of the Lumbosacral Spine clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
This is a global, multi-center, prospective, randomized, blinded, controlled pivotal study. Clinical and radiological evaluation will be performed preoperatively and postoperatively up to 24 months; and endpoint success will be determined at 24 months postoperatively. Overall a maximum of 1017 subjects will be enrolled and treated. The purpose of the study is to provide safety and effectiveness data of Infuse™ in A Transforaminal Lumbar Interbody Fusion (TLIF) procedures and to obtain indication expansion for Infuse™ use in one and two level TLIF procedures.
Irvine, California and other locations
Our lead scientists for Degenerative Disease of the Lumbosacral Spine research studies include Michael Oh.